Skip to content

Health & Schemes: Innovations & Discoveries (2024–2026)

📊 High-Yield Data & Statistical Fact Sheet
  • AB-PMJAY Senior Expansion (2025): Universal cashless health cover of ₹5 Lakh expanded to all senior citizens aged 70+ regardless of income.
  • PM-JANMAN Mission: ₹24,000 Crore saturation program targeting 75 Particularly Vulnerable Tribal Groups (PVTGs) across 18 States/UTs.
  • IHCI (75/25 Initiative): Target to place 75 Million patients with hypertension and diabetes on standard care by 2025.
  • Lakhpati Didi: Target to uplift 3 Crore SHG women to earn a minimum sustainable income of ₹1 Lakh/year.
  • GLASS AMR Findings (WHO 2025): 1 in 3 bacterial infections in India are resistant to standard antibiotics (compared to 1 in 6 globally).
  • PM-Surya Ghar: Provides 300 units of free electricity per month to 1 Crore households via rooftop solar setups.
  • Dengue Burden: India remains among the top 30 countries globally by Dengue incidence; 75–80% of infections are asymptomatic.

1. MAJOR HEALTH & WELFARE SATURATION MISSIONS


MAJOR HEALTH & WELFARE SATURATION MISSIONS

MAJOR HEALTH & WELFARE SATURATION MISSIONS
Cue WordsNotes
Analyze key facts and concepts related to MAJOR HEALTH & WELFARE SATURATION MISSIONS.
  • Ayushman Bharat 70+: In 2024-25, the scheme was expanded to cover every citizen aged 70 and above. Provides a distinct Ayushman Card to track senior-specific health budgets separately from family cards.
  • PM-JANMAN (PVTG Saturation): Focuses on 11 critical interventions (including secure PMAY housing, clean JJM piped water, grid electricity, and dedicated mobile medical units) to saturate India's most vulnerable tribal pockets.
  • IHCI (India Hypertension Control Initiative): A highly successful, decentralized public health intervention monitoring blood pressure control down to sub-center levels.
  • Lakhpati Didi: A micro-credit, bank linkage, and skill training scheme (LED bulb assembly, drone operations, tailoring) designed to convert SHG members into micro-entrepreneurs.

2. VACCINE INNOVATIONS & DISEASE ELIMINATION


VACCINE INNOVATIONS & DISEASE ELIMINATION

VACCINE INNOVATIONS & DISEASE ELIMINATION
Cue WordsNotes
Detail the concepts and significance of Malaria Vaccines: R21 vs RTS,S.
  • R21/Matrix-M: Oxford-developed, low-cost vaccine offering >75% efficacy. Funded and manufactured at scale in India; financed internationally via IFFIm (International Finance Facility for Immunisation).
  • RTS,S/AS01: First-generation GSK vaccine; offers lower efficacy (~30-40%) and suffers from production constraints.
  • AdFalciVax: An indigenous ICMR candidate vaccine targeting P. falciparum CSP protein; formulated with an Alum adjuvant (safer profile).